In person As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies…
Discovery on Target
In person ZoBio will participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small…
FBDD Suitability Screening
Are you unsure whether Fragment Based Drug Discovery is a valid approach for your target?
Fragment Based Drug Discovery is now a well-established method to develop small molecule therapeutics for challenging drug targets. Orthosteric inhibitors, allosteric inhibitors (Asciminib) and Molecular Glues (ImIDs) are just some of the mechanisms of action…
A Fast Route to Success in Molecular Glue Discovery
Are you developing or thinking of developing small molecule therapeutics against a really challengin target? If so, does one of these scenarios describe your situation?
– You are trying to determine which small molecule approach is best for your target (orthosteric/allosteric inhibitor, degrader…